

Echo Therapeutics to Present at the Noble Financial Capital Markets' Eighth Annual Equity Conference
Echo Therapeutics to Present at the Noble Financial Capital Markets' Eighth Annual Equity... -- PHILADELPHIA, Jan. 11, 2012 /PRNewswire/ --
Echo Therapeutics to Present at the Noble Financial Capital Markets' Eighth Annual Equity Conference
PHILADELPHIA, Jan. 11, 2012 /PRNewswire/ -- Echo Therapeutics, Inc. (NASDAQ: [ ECTE ]), a company developing its needle-free Symphony® tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude® SkinPrep System for transdermal drug delivery, today announced that Patrick T. Mooney, M.D., Chairman & CEO of Echo Therapeutics, will present at Noble Financial Capital Markets' Eighth Annual Equity Conference.
Dr. Mooney will make a presentation to prospective corporate partners and investors on Tuesday, January 17th at 12:30 PM ET. The Company's presentation will be delivered at the Hard Rock Hotel in Hollywood, Florida.
At the time of the presentation, a live audio and high-definition video webcast of Echo Therapeutics' presentation and a copy of the presentation materials will be available on the Company's website [ www.echotx.com ] on the Events page or through the Noble Financial websites: [ www.noblefcm.com ] or [ http://www.BOCEM2012.com ]. Echo Therapeutics recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. A Microsoft SilverLight viewer (a free download from the presentation link) is required to participate. The webcast and presentation will also be archived on [ www.echotx.com ] for 30 days following the event.
About Echo Therapeutics
Echo is developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system for patients with diabetes and for use in hospital critical care units. Echo is also developing its needle-free Prelude SkinPrep System as a platform technology for enhanced skin permeation for delivery of topical pharmaceuticals.
For More Information:
Christine Olimpio
Director, Investor Relations & Corporate Communications
(215) 717-4104
Connect With Us:
- Visit our website at [ www.echotx.com ]
- Follow us on Twitter at [ www.twitter.com/echotx ]
- Join us on Facebook at [ www.facebook.com/echotx ]
SOURCE Echo Therapeutics, Inc.
[ Back to top ] RELATED LINKS
[ http://www.echotx.com ]